← Back to headlines
Syndax Pharmaceuticals Prices $250 Million Senior Convertible Notes
Syndax Pharmaceuticals has announced the pricing of $250 million in senior convertible notes.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
